Hypertension in men

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 10, 1999, Pages 3451-3454

  August, Phyllis ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHLORTALIDONE; DIURETIC AGENT; DOXAZOSIN;

BEHAVIOR MODIFICATION; ERECTILE DYSFUNCTION; HUMAN; HYPERTENSION; MALE; NOTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SLEEP APNEA SYNDROME;

EID: 0033305366     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.10.6124     Document Type: Note

References (35)

1. Hypertension in women
2. High blood pressure in women
3. Prevalence of hypertension in the U.S. adult population: Results of the Third National Health and Nutrition Examination Survey, 1988-1991
4. Hypertension screening of 1 million Americans. Community Hypertension Evaluation Clinic (CHEC) Program, 1973-1975
5. Blood pressure as a cardiovascular risk factor. Prevention and treatment
6. Systolic vs. diastolic blood pressure and risk of coronary heart disease: The Framingham Study
7. End-stage renal disease in African American and white men; 16-year MRFIT findings
8. The protective effects of estrogen on the cardiovascular system
9. Role of androgens in mediating hypertension and renal injury
10. Testosterone exacerbates hypertension and reduces pressure-natriuresis in male spontaneously hypertensive rats
11. Influence of gender on the level of pulse pressure: The role of large conduit arteries
12. Blood pressure and the progression of carotid atherosclerosis in middle aged men
13. Evidence for association and genetic linkage of the angiotensin-converting locus with hypertension and blood pressure in men but not women in the Framingham Heart Study
14. Exercise stress testing
15. Diagnostic accuracy of exercise thallium-201 scintigraphy in men with asymptomatic essential hypertension
16. Serum uric acid and cardiovascular events in successfully treated hypertensive patients
17. Uric acid as an independent risk factor in the treatment of hypertension
18. Sleep-related breathing disorders as a major cause of essential hypertension: Fact or fiction?
19. Epidemiology of obstructive sleep apnea syndrome
20. Size and mechanical properties of the pahrynx in healthy men and women
21. Gender differences in airway resistance during sleep
22. Obstructive sleep apnea syndrome in male hypertensives, refractory to drug therapy. Nocturnal automatic blood pressure measurements -an aid to diagnosis?
23. Acute effects of nasal continuous positive airway pressure on 24-hour blood pressure and catecholamines in patients with obstructive sleep apnea
24. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model
25. Sleep-related breathing disorders are common contributing factors to the production of essential hypertension but are neglected, underdiagnosed, and undertreated
26. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg
27. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 90 through 114 mm Hg
28. Blood pressure, stroke, and coronary heart disease. Part 2. Short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context
29. Hypertension in the elderly
30. Treatment of hypertension: Rationale, guidelines, and goals
31. The sixth report of the Joint National Committee (JNC VI) on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
32. The treatment of mild hypertension: A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug mono-therapies